SUBSCRIBE
SUBSCRIBE

Patient recruitment

PRESS RELEASES
Press Releases
Vistagen Initiates Fasedienol Repeat Dose Study for the Acute Treatment of Social Anxiety Disorder
January 10, 2025
 · 
7 min read
Press Releases
Argon Medical Announces First Patient Enrollment in CLEAN-PE, a Prospective, Multicenter Study of a New Treatment for Pulmonary Embolism
January 9, 2025
 · 
3 min read
Press Releases
Arch Biopartners Announces Ontario Research Ethics Board Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
January 9, 2025
 · 
6 min read
Press Releases
EsoBiotec Doses First Patient in Investigator Initiated Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma
January 9, 2025
 · 
5 min read
Press Releases
Palvella Therapeutics Announces First Patients Dosed in Phase 2 TOIVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Cutaneous Venous Malformations
January 9, 2025
 · 
7 min read
Press Releases
Replimune Announces RP2 Development Program Advances with First Patients Enrolled in Metastatic Uveal Melanoma and Hepatocellular Carcinoma Clinical Trials
January 9, 2025
 · 
6 min read
Press Releases
BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson’s Disease
January 7, 2025
 · 
5 min read
Press Releases
Patient Enrolment Completed for INSIGHT-003
January 6, 2025
 · 
2 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Opening of First Clinical Site
December 30, 2024
 · 
4 min read
Press Releases
Axena Health Begins Patient Enrollment for UI Treatment Study at Two Sites in Nigeria
December 23, 2024
 · 
7 min read
Press Releases
Ellipses Launches Pioneering Clinical Trial Programme in Middle East
December 23, 2024
 · 
4 min read
Press Releases
Coya Therapeutics Provides Enrollment Update of the Investigator-Initiated Phase 1 Study of Low Dose Interleukin-2 (LD IL-2) + CTLA4-Ig Fusion Protein in Patients with Frontotemporal Dementia (FTD)
December 18, 2024
 · 
10 min read
Press Releases
Tiziana Life Sciences Announces First Patient with Moderate Alzheimer’s Disease Dosed with Intranasal Foralumab
December 18, 2024
 · 
6 min read
Press Releases
Transpire Bio Achieves Important Corporate Milestone with Completion of First Human Subject Study in the Company’s Asthma and Chronic Obstructive Pulmonary Disease Inhaled Drug Program
December 18, 2024
 · 
1 min read
Press Releases
First-In-Human Study Demonstrates the Potential of the Reprieve System in Patients with Acute Decompensated Heart Failure
December 16, 2024
 · 
5 min read
Press Releases
Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial
December 10, 2024
 · 
7 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Site Initiation Visit Completed
December 9, 2024
 · 
3 min read
Press Releases
The Multiple Myeloma Research Foundation (MMRF) Announces the First Patient Enrolled in its Horizon Clinical Trials Program to Accelerate the Identification of Optimal Treatment Strategies for Multiple Myeloma
December 5, 2024
 · 
3 min read
Press Releases
Delta-Fly Pharma Inc.: Update for Development Status of DFP-17729
December 5, 2024
 · 
1 min read
Press Releases
SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial
December 4, 2024
 · 
8 min read
Load More